U.S. Markets open in 13 hrs, 8 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 45.40 09:30 AM EST | |
|---|---|---|
| Day High | 46.61 09:50 AM EST |
|
| Range | 1.21 |
| Volume | 8.65 M | |
|---|---|---|
| 30-Day Avg Vol | 8.66 M |
|
| Difference | -0.09% |
| Market Cap | 41.83 B | |
|---|---|---|
| Mkt Cap Chg | 687.23 M |
| Shares Out | 904.26 M | |
|---|---|---|
| % Shrs Traded | 0.96% | |
| 1yr EPS Est | 3.16 |
| 52-Wk Low | 39.37 | |
|---|---|---|
| 52-Wk High | 53.28 |
|
| Range | 13.91 |
| Prev Close | 45.50 11/5/09 | |
|---|---|---|
| Today's Open | 45.49 | |
| Change | -0.02% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 14.7 M |
| Revenue (LFY) | 5.33 B | |
|---|---|---|
| Earnings (LFY) | 2.01 B | |
| Earnings (MRQ) | 673.03 M | |
| Next Earn Est | 0.809 | |
| Next Earnings | 01/27/2010 |
|
| EPS (TTM) | 2.56 | |
| 1yr EPS Growth | 23.44% |
| P/E Ratio (TTM) | 17.33 | |
|---|---|---|
| P/E Ratio (Fwd) | 14.00 | |
| PEG Ratio | 0.92 | |
| Return on Equity | 53.05 | |
| Beta | 0.45 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes blockbuster Truvada, a combination of two of its ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.809 1/27/10 | — — |
—
—
|
| Last Quarter | 0.673 9/30/09 | 0.72 9/30/09 |
0.047
Beat
|
| 2 Quarters Ago | 0.614 6/30/09 | 0.61 6/30/09 |
-0.004
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 1.80 B | 5.34 B |
| Gross Profit | 1.39 B | 4.21 B |
| Operating Income | 894.41 M | 2.69 B |
| Net Income | 673.03 M | 2.01 B |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts